Navigation Links
Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids
Date:5/31/2008

Data Show TriLipix (ABT-335) in Combination with CRESTOR (rosuvastatin

calcium) Improved LDL, HDL and Triglycerides and Had Reported Safety

Consistent with Monotherapies

SEATTLE, May 31 /PRNewswire-FirstCall/ -- New Phase III data showed that in patients with multiple lipid problems, Abbott's investigational TriLipix(TM) (ABT-335) combined with AstraZeneca's CRESTOR(R) (rosuvastatin calcium) led to greater improvements than the corresponding monotherapy in treating all three key lipids -- LDL "bad" cholesterol, HDL "good" cholesterol and triglycerides. Results from this Phase III study were presented today at the National Lipid Association's 2008 Scientific Sessions in Seattle.

This study of more than 1,400 patients is part of the largest clinical program to date designed to evaluate the efficacy and safety of a fibrate in combination with statins. Data from the study showed that TriLipix in combination with rosuvastatin met its primary endpoints with significantly greater improvements in HDL and triglycerides compared to rosuvastatin alone, and significantly greater improvements in LDL compared to TriLipix alone. Both the combinations and rosuvastatin alone resulted in clinically meaningful reductions in LDL. In the clinical trial, TriLipix in combination with rosuvastatin was generally well tolerated, with reported safety similar to the monotherapies. No rhabdomyolysis (a rare muscle disorder) or unexpected liver, kidney or muscle safety issues were identified in this study.

"Patients with mixed dyslipidemia may need treatment options that help address these three key lipids," said Peter H. Jones, M.D., FACP, Methodist DeBakey Heart and Vascular Center, Houston, and a lead investigator of the trial. "Results from this study showed that TriLipix in combination with rosuvastatin significantly increased HDL, and decreased both LDL and triglycerides."

According to the American Heart Association (AHA), mo
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2008)... , CHICAGO, Dec. 1 ...d cerebral blood flow and a greater number of smal...s presented today at the annual meeting of the Rad..., The study, conducted at the University of No...to compare brain scans of older adults who exercis...
(Date:11/28/2008)...GÿRLITZ, Germany, November 28 Ger...l leadership in specialized HIV monitoring and,AI...d emerging countries. In,the year 2008, 2.5 milli...table, robust and highly affordable "CyFlow" syste...living with HIV/AIDS. Due to introduction of the,...
(Date:11/27/2008)...study finds the majority of acute lymphoblastic le...sent at the time of diagnosis , , MEMPHIS, ...ts at St. Jude Children,s Research Hospital have i...r cells of children with acute lymphoblastic leuke... pathway to designing treatments for ALL relapse i...
(Date:11/26/2008)...eased information density, automation and intellig... in ultrasound to an all new level , , CHIC...ens Healthcare ( www.siemens.com/healthcare ) ...olume Scanner (ABVS)(1), the world,s first multi-... the 94th Scientific Assembly and Annual Meeting o...
Breaking Medicine Technology:Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103 Vidaza 28R 29 Study in Myelodysplastic Syndromes and Acute Myelogeno 7980 1Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103 Vidaza 28R 29 Study in Myelodysplastic Syndromes and Acute Myelogeno 7980 2Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103 Vidaza 28R 29 Study in Myelodysplastic Syndromes and Acute Myelogeno 7980 3Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103 Vidaza 28R 29 Study in Myelodysplastic Syndromes and Acute Myelogeno 7980 4Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103 Vidaza 28R 29 Study in Myelodysplastic Syndromes and Acute Myelogeno 7980 5Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103 Vidaza 28R 29 Study in Myelodysplastic Syndromes and Acute Myelogeno 7980 6Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103 Vidaza 28R 29 Study in Myelodysplastic Syndromes and Acute Myelogeno 7980 7Jan Marini Skin Research Adds Two New Sheer Colors to Antioxidant Daily Face Protectant SPF 30 With PhytoMelanin 28TM 29 7977 1Jan Marini Skin Research Adds Two New Sheer Colors to Antioxidant Daily Face Protectant SPF 30 With PhytoMelanin 28TM 29 7977 2San Antonio Breast Cancer Symposium December 13th to 16th 2007 7974 1San Antonio Breast Cancer Symposium December 13th to 16th 2007 7974 2Gentler chemotherapy before stem cell transplant causes long term remission of follicular lymphoma 7971 1Gentler chemotherapy before stem cell transplant causes long term remission of follicular lymphoma 7971 2
...NESS WIRE)--May 17, 2007 - BioLineRx Ltd. (TASE:,B...nnounced today,that abstracts containing data from...s of BL-1020, first in class GABA-enhanced,antipsy...en,accepted for poster presentations at three lead...nted at the following,conferences:, -- Society of ...
...(BUSINESS WIRE)--May 18, 2007 - AVANT,Immunotherap...ve,preliminary results from an investigational dou...ating clinical trial of its,typhoid fever vaccine ...rchers found the single-dose, oral vaccine to be w...ccinated subjects,generating immune responses. Bas...
Other Medicine Technology:BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 2BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 3Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical,Potential 2Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical,Potential 3Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical,Potential 4Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical,Potential 5
(Date:12/1/2008)...gene repressors for anticancer therapy , Miche...ring Cancer Center, New York, have developed a new...therapeutic purposes, and used this to mediate eff...oding RNA molecules known as miRNAs are powerful n..., the miRNA miR-181a was harnessed to segregate ex...
(Date:12/1/2008)...ntrepreneur, television and,radio host Ryan Seacr...hn,Bendheim will be honored by the Cedars-Sinai B..." Gala, December 2, 2008, at the Hyatt Regency Cen...oard of Governors, co-chairs the,event with Debbe...The "Road To,A Cure" Gala is sponsored by Lexus, ...
(Date:12/1/2008)...-- Democratic National Committee Chairman Howard D...ting World AIDS Day on its 20th Anniversary: , ...20080519/DNCLOGO ) , , "It,s been 20 years ...made strides, much work remains to be done to tack...trategy. We must focus not only on preventing the...
(Date:12/1/2008)... -- Americans United for Life (AUL) today announc...tion opposing the federal "Freedom of Choice Act" ... resolution immediately when they convene their 20...resident & CEO said, "The so-called ,Freedom o...ts and promotes the abortion industry, sacrifices ...
Breaking Medicine News(10 mins):Health News:JCI online early table of contents: Dec. 1, 2008 2Health News:JCI online early table of contents: Dec. 1, 2008 3Health News:JCI online early table of contents: Dec. 1, 2008 4Health News:Cedars-Sinai Board of Governors to Honor Ryan Seacrest & John Bendheim at Annual 'Road To A Cure' Gala 2Health News:Americans United for Life Urges State Legislatures to Oppose Federal Power Grab: Provides Model Resolution Denouncing Freedom of Choice Act (FOCA) 2
...the brain areas preoperative brain could effective...at is to appear in the September issue of Radiolog...// and language areas of the brain with functional...uld help the surgeons in pinpointing the brain tum...
...in almost every medicine cabinet, may help in easi...innesota's Mayo Clinic.// Aspirin is known to hel...art attacks, strokes and several types of cancer a...ay that now it may help solve some of the urinary ...
... was described as being one of the crown jewels in...mmersmith Hospitals NHS Trust acquired the// hospi...d predicted that the hospital had a great future i...which had six theatres and 105 beds, was revamped ...
...s suspected of having the human variety of mad cow...nd was admitted to a Hog Kong hospital// after he ...ong said the man came to the country on April 4 an... The man is of Chinese origin and underwent intes...
Other Medicine News:Health News:fMRI Prior to surgery Could Help In Outcome Of Tumor Surgery 2Health News:fMRI Prior to surgery Could Help In Outcome Of Tumor Surgery 3
... aspherical optics. Includes XHL halogen bulb. The...y means of the aspherical optical system avoids co...Beta 200 allows you to view the whole of the illum...il. Conventional ophthalmoscopes often let you see...
The Panoptic ophthalmoscope incorporates an innovative and patented new optical design called axial Pointsource optics. This enabling technology makes it easier to enter small pupils and provides a d
Woodlyn Refractor offers the option to either rotate the better-one better-two refinement knob, or rotate the low sphere disc.
The Ultramatic Rx Master is designed and constructed to provide years of reliable service and give the professional distinctive features that measurably improve procedures. It embodies the characteri
Medicine Products: